Efficacy and safety of mRNA and AstraZeneca COVID-19 vaccines in patients with autoimmune rheumatic diseases: A systematic review
<h3>Background</h3><p dir="ltr">Patients with autoimmune rheumatic diseases (ARD) are at a potentially higher risk for COVID-19 infection complications. Given their inherent altered immune system and the use of immunomodulatory medications, vaccine immunogenicity could be...
Saved in:
| Main Author: | Anwar I. Joudeh (16003142) (author) |
|---|---|
| Other Authors: | Abdu Qaid Lutf (16003145) (author), Salah Mahdi (14779066) (author), Gui Tran (3739468) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Immunomodulatory Role of Microbiota in Rheumatic Heart Disease: What Do We Know and What Can We Learn from Other Rheumatic Diseases?
by: Amira Kohil (15257285)
Published: (2023) -
Post-Thymectomy Autoimmune Flare-Up With New-Onset Type 1 Diabetes Mellitus
by: Tareq Al-Bkoor (21767192)
Published: (2024) -
The role of soluble CD40L in autoimmune diseases
by: Meryem, Mabrouk
Published: (2025) -
Evaluating patient adherence in heart disease
by: Nature Research (16552612)
Published: (2015) -
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases
by: Abdul Q. Khan (14153247)
Published: (2022)